Countries share the costs of the vaccine programmes by directly co-procuring a portion of the vaccines and safe injection devices from a supplier or procurement agency to fulfil their co-financing requirements.
As a country’s gross national income (GNI) per capita increases, so the level of its co-financing payments also rises. Countries are grouped under different categories according to their level of GNI per capita as a proxy of their ability to pay.
Low-income countries (GNI per capita below US$ 995 in 2019) are classified as “initial selffinancing.”
As their income per capita increases, they enter a “preparatory transition” phase.
Countries then enter five years of “accelerated transition” once they cross the Gavi eligibility threshold (US$ 1,580 per capita in 2019).
At the end of five years, they become fully self-financing. Currently, there are 16 such countries.
By the end of 2019, 16 countries had transitioned to fully self-financing. All of them are successfully maintaining and self-financing their immunisation programmes. As a growing number of countries transition from Gavi support, we are helping them lay the foundation to continue sustainably financing and managing their vaccination programmes. We work to support institutional capacity development, and strengthening health and immunisation systems, so that countries are able to maintain high levels of immunisation after they have completed the transition to self-funding.
Gavi, the Vaccine Alliance helps vaccinate almost half the world’s children against deadly and debilitating infectious diseases.
The annual progress report gives a comprehensive overview of the activities and performance of Gavi, the Vaccine Alliance, illustrating the work and achievements of this public-private partnership